a cure for hep c, aids, the flu and dengue..., page-88

The announcement is quite a fascinating read. The research is entirely independent of Biotron, though, by explaining the role of Vpu in the process of HIV infection, it finally describes and confirms the mechanisms that BIT's Vpu drug utilises to destroy HIV and reservoir cells.

In what the company describes as the "final holy grail" of HIV drugs, the reservoir cells that hide the HIV virus would finally become "visible" to our immune systems, allowing total eradication. A cure for HIV.

The study unintentionally vindicates BIT's HIV drug design. It would be a mistake to think this information is only of minor consequence. Nor is it just a way of rephrasing the information previously available to the public. The peer-reviewed published research conducted by the Rush university Medical Complex strongly fortifies the position of the company going into funding and partnership negotiations for the phase II HIV human trials.


Cheers

Tawny